Since it was discovered that the hazards of body hormone therapy outweighed the benefits, experts have been trying to find a safe, normal way to ease the indications of Aging
Individuals are currently becoming recruited for your follow-up clinical trial of the treatment generally known as MF101 manufactured by Bionovo, Incorporation. In its preliminary clinical trial, MF101 presented women in the study with preliminary evidence of relief from many of these symptoms since hot whizzes and nighttime sweats, without the risks associated with hormone therapy.
The treatment becoming tested clinically targets only one of the two known estrogen receptors-the estrogen receptor beta. Laboratory info has shown that MF101 does not cause the proliferation of breast or perhaps uterine cancer tumor cells just how hormone remedy can, producing the drug a more secure alternative to currently available hormone remedies.
In 2002, the Could Health Project (WHI) Estrogen Plus Progestin Trial, with over 16, 000 girls participants, was stopped early when it was found that the standard dose of mix hormone therapy increased the chance of breast cancer, stroke, heart problems, blood clots and dementia.
“Given the void that exists to get a safe and effective treatment for menopausal symptoms, each of our aim is always to discover and develop novel drugs including MF101 that could abate most of the symptoms which may have historically recently been treated with hormones, very well said Dr . Mary Tagliaferri. Tagliaferri is certainly co-author of “The New Menopause Reserve: The Experts Help You Make Informed Decisions on HORMONE REPLACEMENT THERAPY, Natural Body hormone Therapy, Plant based Therapies, Traditional Chinese Medicine And More” (Avery, 2006) and Chief Medical Officer of Bionovo, which can be developing the drug.
The clinical trials will be held at under the directorship of famous researcher Doctor Deborah Grady at 4 leading educational medical centers.
Bionovo can expect this Period 2 trial to be accomplished by the second 1 / 4 of 2018.
“If this new drug proves to be effective, we are providing health care practitioners with a treatment they can comfortably advise to women of all ages experiencing menopause, ” explained Dr . Tagliaferri.